UNSPSC 51401539: Motrazepam

This classification denotes an anxiolytic with the molecular formula C17H15N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36YG4ZMR69, chemically known as 2,3-dihydro-1-(methoxymethyl)-7-nitro-5-phenyl-1h-1,4-benzodiazepin-2-on but generally known as motrazepam, which bears US NIH Compound Identifier 65764. European Medicines Agency schedules Motrazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09076MIG.

UNSPSC 51401539 Motrazepam is a Commodity code that does not align with the recent state and local procurement activity posted under it. Seminole County, Florida's solicitation (IFB 60459723LAS) seeks Naloxone and Safe Drug Deactivation Systems—products unrelated to motrazepam—suggesting a tagging mismatch in the source data. The county is procuring 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through a competitive IFB process with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify requirements and drug-free workplace certification. The contract carries an initial two-year term with one-year renewal option and includes a three-month probationary period, with potential FEMA funding triggering additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

The code shows little relevant recent activity. The single opportunity on record—Seminole County's naloxone and drug deactivation systems purchase with a response deadline of July 26, 2023—does not match the motrazepam commodity scope. Without additional state and local solicitations tagged to this code in the current dataset, no geographic concentration or issuing-body pattern can be established.